Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Sangamo Shares Soar as Hemophilia Drug Shows Promise
By Scott Van Voorhis
Jul 8, 2019 11:10 AM EDT
STOCKS
Spark Therapeutics' Shares Misfire on Roche Acquisition Delay
By M. Corey Goldman
Jun 10, 2019 11:01 AM EDT
INVESTING
Roche Buys More Time in $4.3B Offer for Spark Therapeutics
By M. Corey Goldman
Apr 3, 2019 9:43 AM EDT
STOCKS
Trading Roku Stock as Downgrades Sap Its Run to New Highs
By Bret Kenwell
Mar 13, 2019 1:20 PM EDT
JIM CRAMER
Win, With or Without China: Cramer's 'Mad Money' Recap
By Scott Rutt
Feb 25, 2019 8:57 PM EST
MARKETS
3 Things to Know at Market Close: ETF Inflows, Spark Therapeutics, Palo Alto
By Jacob Sonenshine
Feb 25, 2019 4:19 PM EST
MARKETS
Dow Closes Modestly Higher After Trump Extends China Tariff Deadline
By Joseph Woelfel
Feb 25, 2019 4:06 PM EST
STOCKS
Spark Therapeutics Rockets as Roche Pays $4.3 Billion for Gene Therapy Experts
By Martin Baccardax
Feb 25, 2019 11:37 AM EST
MARKETS
Trade Talks, Spark, Buffett, Kraft Heinz, 'Green Book' - 5 Things You Must Know
By Joseph Woelfel
Feb 25, 2019 8:05 AM EST
STOCKS
Stocks Gain, China Surges, as Trump Delays Tariffs Amid Trade Talk Progress
By Martin Baccardax
Feb 25, 2019 7:37 AM EST
MARKETS
Roche to Buy Spark for $4.8 Billion
By Adam Smith
Feb 25, 2019 1:28 AM EST
MARKETS
Roche Aims to Buy Spark for $5 Billion: Wall Street Journal
By Adam Smith
Feb 24, 2019 12:45 PM EST
STOCKS
3 Biotech Stock Favorites to Bet on Today: Top Analysts
By Tip Ranks
Aug 13, 2018 8:00 AM EDT
STOCKS
7 Winners and Losers From Biggest Biotech Conference of 2017
By Tony Owusu
Dec 13, 2017 11:34 AM EST
STOCKS
Bluebird Bio Becoming Household Name With This Promising Cancer Treatment
By Bret Kenwell
Dec 11, 2017 12:23 PM EST
REGULATION
FDA Advisory Committee Greenlights First Gene Therapy For Inherited Disorder
By Bill Meagher
Oct 12, 2017 7:26 PM EDT
HEALTH
Illumina Shares Jump on Better-Than-Expected Second-Quarter Numbers
By Armie Margaret Lee
Aug 2, 2017 11:17 AM EDT
HEALTH
Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks
By Armie Margaret Lee
Jul 14, 2017 4:11 PM EDT
STOCKS
Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
By Adam Feuerstein
Dec 5, 2016 1:11 PM EST
STOCKS
Spark's hemophilia gene therapy remains effective despite immune reactions
By Adam Feuerstein
Dec 3, 2016 1:04 PM EST
STOCKS
The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
By Adam Feuerstein
Nov 3, 2016 10:31 AM EDT
OPINION
Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell
By Scott Rutt
Sep 9, 2016 6:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: This Market Has a One-Track Mind
By Scott Rutt
Sep 8, 2016 8:16 PM EDT
OPINION
13 companies to watch from MIT's smart 50 list, including 4 buys
By Robert Wasserman
Jul 21, 2016 7:48 AM EDT
MARKETS
Strong On High Relative Volume: Spark Therapeutics (ONCE)
By TheStreet Wire
Jul 12, 2016 10:02 AM EDT
